Nearwater Capital Markets, Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 1915842
NEW YORK, NY
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,123,700
New position
Shares Held
155,000
first reported quarter
Ownership
0.152%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#99
of 774 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Nearwater Capital Markets, Ltd holds $33,756,700 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (77.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
155,000 | $26,123,700 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
425,000 | $7,633,000 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,123,700 | 155,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||